Rxsight (RXST)Ra Capital Management, L.P. exited its position 3.7M shares

3.7M

Prior-quarter shares · no longer reported

Holdings as of

Sep 30, 2025

Filed

Nov 14, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Nov 5, 2025Company filing · Form 8-K · ResultsReported its results

What came next

1. Dec 16, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On December 16, 2025, Shelley Thunen notified RxSight, Inc. (the “Company”) of her intention to transition from her position as the Company’s Chief Financial Officer (and principal financial and accounting officer), effective upon the sooner of the appointment of her successor as Chief Financial Officer or January 31, 2026.”
2. Dec 18, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 18, 2025, the Board of Directors (the “Board”) of RxSight, Inc. (the “Company”) appointed Eric Weinberg to the executive officer position of Chief Business Development Officer concurrent with his transition from the Chief Commercial Officer position on the same date.”
3. Dec 23, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“In connection with the previously announced pending transition of Shelley Thunen from her position as the Company’s Chief Financial Officer (and principal financial and accounting officer), on December 23, 2025, RxSight, Inc. (the “Company”) and Ms. Thunen entered into a transition agreement and release of claims (the “Transition Agreement”) and a consulting agreement, effective as of her employment separation date,…”
4. Jan 11, 2026Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results (and 1 more item)“On December 13, 2025, the Company appointed Mark Wilterding as its Chief Financial Officer (and principal financial and accounting officer), effective January 11, 2026 (the “Effective Date”), replacing Shelley Thunen in such capacities.”
5. Feb 25, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Rxsight

For Rxsight, OQRO holds 4 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RXST page.

How this filing works

• SEC Form 13F

Other disclosures at Rxsight

• SEC Form 4Sep 3, 2026
• SEC Form 4Sep 3, 2026
• SEC Form 4Sep 3, 2026
• SEC Form 4Sep 3, 2026
• SEC Form 13F-HRAug 14, 2025
• SEC Form 13F-HRAug 14, 2025

Everything OQRO holds on this company is on its RXST page.